(A) BRAF Chr 7:140477836 (c.1457_1471delATGTGACAGCACCTA_p.Asn486_Pro490del) as visualized in whole-genome sequencing (top track, WGS-Tumor), whole-exome sequencing (center track, WES-Tumor), and blood normal sample (lower track, Normal). (B) Sanger sequencing electropherogram confirming the BRAF ΔNVTAP variant. (C) Location of the deletion variant in BRAF protein (red) and residues involved in a potential salt bridge (green) (PDB:1UWH). (D) CA 19-9 marker serum levels (units/mL) over time. (E) Patient CT scan of pre- (left) and post- (right) dabrafenib treatment demonstrating decrease in the hepatic metastatic tumor burden posttreatment.